Literature DB >> 16412434

The AP-1/CJUN signaling cascade is involved in muscle differentiation: implications in muscle wasting during cancer cachexia.

Rodrigo Moore-Carrasco1, Celia García-Martínez, Sílvia Busquets, Elisabet Ametller, Esther Barreiro, Francisco J López-Soriano, Josep M Argilés.   

Abstract

The aim of the present study was to investigate a possible role of the AP-1 signaling cascade in the process of wasting associated with cancer cachexia at the level of skeletal muscle. The injection of virus containing the TAM67 protein (a blocker of the AP-1 protein) to the gastrocnemius muscle of tumour-bearing rats resulted in a significant recovery of the muscle mass (which is dramatically reduced as a result of tumour burden), therefore suggesting that AP-1 is certainly involved in the signaling associated with muscle protein accretion. In conclusion, the gene therapy approach presented here clearly suggests an important role for AP-1 in muscle signaling during catabolic states.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16412434     DOI: 10.1016/j.febslet.2005.12.084

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  Sepsis and glucocorticoids upregulate p300 and downregulate HDAC6 expression and activity in skeletal muscle.

Authors:  Nima Alamdari; Ira J Smith; Zaira Aversa; Per-Olof Hasselgren
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-06-10       Impact factor: 3.619

2.  Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia.

Authors:  Yu-Chou Tseng; Samuel K Kulp; I-Lu Lai; En-Chi Hsu; Wei A He; David E Frankhouser; Pearlly S Yan; Xiaokui Mo; Mark Bloomston; Gregory B Lesinski; Guido Marcucci; Denis C Guttridge; Tanios Bekaii-Saab; Ching-Shih Chen
Journal:  J Natl Cancer Inst       Date:  2015-10-12       Impact factor: 13.506

3.  C/EBPβ regulates dexamethasone-induced muscle cell atrophy and expression of atrogin-1 and MuRF1.

Authors:  Patricia Gonnella; Nima Alamdari; Steven Tizio; Zaira Aversa; Victoria Petkova; Per-Olof Hasselgren
Journal:  J Cell Biochem       Date:  2011-07       Impact factor: 4.429

4.  A direct HDAC4-MAP kinase crosstalk activates muscle atrophy program.

Authors:  Moon-Chang Choi; Todd J Cohen; Tomasa Barrientos; Bin Wang; Ming Li; Bryan J Simmons; Jeong Soo Yang; Gregory A Cox; Yingming Zhao; Tso-Pang Yao
Journal:  Mol Cell       Date:  2012-05-31       Impact factor: 17.970

5.  Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition.

Authors:  Fabio Penna; Domiziana Costamagna; Alessandro Fanzani; Gabriella Bonelli; Francesco M Baccino; Paola Costelli
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

6.  Expression of NF-kappaB and IkappaB proteins in skeletal muscle of gastric cancer patients.

Authors:  Mary G Rhoads; Susan C Kandarian; Fabio Pacelli; Giovan Battista Doglietto; Maurizio Bossola
Journal:  Eur J Cancer       Date:  2010-01       Impact factor: 9.162

7.  Sepsis increases the expression and activity of the transcription factor Forkhead Box O 1 (FOXO1) in skeletal muscle by a glucocorticoid-dependent mechanism.

Authors:  Ira J Smith; Nima Alamdari; Patrick O'Neal; Patricia Gonnella; Zaira Aversa; Per-Olof Hasselgren
Journal:  Int J Biochem Cell Biol       Date:  2010-01-13       Impact factor: 5.085

8.  Galectin-3 increases the motility of mouse melanoma cells by regulating matrix metalloproteinase-1 expression.

Authors:  Yuan-Guo Wang; Seok-Jun Kim; Jung-Hwan Baek; Hyun-Woo Lee; Seo-Young Jeong; Kyung-Hee Chun
Journal:  Exp Mol Med       Date:  2012-06-30       Impact factor: 8.718

Review 9.  Roles and potential therapeutic targets of the ubiquitin proteasome system in muscle wasting.

Authors:  David Nury; Christine Doucet; Olivier Coux
Journal:  BMC Biochem       Date:  2007-11-22       Impact factor: 4.059

10.  Meta-analysis of expression signatures of muscle atrophy: gene interaction networks in early and late stages.

Authors:  Enrica Calura; Stefano Cagnin; Anna Raffaello; Paolo Laveder; Gerolamo Lanfranchi; Chiara Romualdi
Journal:  BMC Genomics       Date:  2008-12-23       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.